These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin. Gallo M; Coutinho FJ; Vanner RJ; Gayden T; Mack SC; Murison A; Remke M; Li R; Takayama N; Desai K; Lee L; Lan X; Park NI; Barsyte-Lovejoy D; Smil D; Sturm D; Kushida MM; Head R; Cusimano MD; Bernstein M; Clarke ID; Dick JE; Pfister SM; Rich JN; Arrowsmith CH; Taylor MD; Jabado N; Bazett-Jones DP; Lupien M; Dirks PB Cancer Cell; 2015 Dec; 28(6):715-729. PubMed ID: 26626085 [TBL] [Abstract][Full Text] [Related]
3. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC. Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712 [TBL] [Abstract][Full Text] [Related]
4. Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin. Romero-Reyes J; Vázquez-Martínez ER; Silva CC; Molina-Hernández A; Díaz NF; Camacho-Arroyo I Mol Biol Rep; 2024 Aug; 51(1):912. PubMed ID: 39153092 [TBL] [Abstract][Full Text] [Related]
5. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma. Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801 [TBL] [Abstract][Full Text] [Related]
6. E2F and STAT3 provide transcriptional synergy for histone variant H2AZ activation to sustain glioblastoma chromatin accessibility and tumorigenicity. Yoon J; Grinchuk OV; Tirado-Magallanes R; Ngian ZK; Tay EXY; Chuah YH; Lee BWL; Feng J; Crasta KC; Ong CT; Benoukraf T; Ong DST Cell Death Differ; 2022 Jul; 29(7):1379-1394. PubMed ID: 35058574 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of metabolism in glioblastoma. Dong Z; Cui H Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139 [TBL] [Abstract][Full Text] [Related]
8. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells. Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745 [TBL] [Abstract][Full Text] [Related]
9. ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways. Wang F; Wang AY; Chesnelong C; Yang Y; Nabbi A; Thalappilly S; Alekseev V; Riabowol K Oncogene; 2018 Jan; 37(3):286-301. PubMed ID: 28925404 [TBL] [Abstract][Full Text] [Related]
10. Glioma Stem-like Cells Keep Their H3.3 Variant Levels at Bay. Becher OJ; Holland EC Cancer Cell; 2015 Dec; 28(6):679-680. PubMed ID: 26678332 [TBL] [Abstract][Full Text] [Related]
11. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma. Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055 [TBL] [Abstract][Full Text] [Related]
12. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters. Yoo S; Bieda MC BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646 [TBL] [Abstract][Full Text] [Related]
13. Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation. Mallm JP; Windisch P; Biran A; Gal Z; Schumacher S; Glass R; Herold-Mende C; Meshorer E; Barbus M; Rippe K Int J Cancer; 2020 Mar; 146(5):1281-1292. PubMed ID: 31456217 [TBL] [Abstract][Full Text] [Related]
14. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness. Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419 [TBL] [Abstract][Full Text] [Related]
15. METTL8 links mt-tRNA m Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809 [TBL] [Abstract][Full Text] [Related]
16. Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells. Zhang B; Gu X; Han X; Gao Q; Liu J; Guo T; Gao D Clin Epigenetics; 2020 Mar; 12(1):47. PubMed ID: 32183903 [TBL] [Abstract][Full Text] [Related]
17. Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma. Dahl NA; Danis E; Balakrishnan I; Wang D; Pierce A; Walker FM; Gilani A; Serkova NJ; Madhavan K; Fosmire S; Green AL; Foreman NK; Venkataraman S; Vibhakar R Cell Rep; 2020 Apr; 31(1):107485. PubMed ID: 32268092 [TBL] [Abstract][Full Text] [Related]
18. A system for genome-wide histone variant dynamics in ES cells reveals dynamic MacroH2A2 replacement at promoters. Yildirim O; Hung JH; Cedeno RJ; Weng Z; Lengner CJ; Rando OJ PLoS Genet; 2014 Aug; 10(8):e1004515. PubMed ID: 25102063 [TBL] [Abstract][Full Text] [Related]
19. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Gao X; Jin W Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866 [TBL] [Abstract][Full Text] [Related]
20. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme. Li Q; Dong C; Cui J; Wang Y; Hong X J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]